Absorption |
Blood-Brain Barrier | BBB- | 0.9155 |
Human Intestinal Absorption | HIA+ | 0.8902 |
Caco-2 Permeability | Caco2- | 0.7278 |
P-glycoprotein Substrate | Substrate | 0.7928 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8376 |
Non-inhibitor | 0.5813 |
Renal Organic Cation Transporter | Non-inhibitor | 0.6701 |
Distribution |
Subcellular localization | Mitochondria | 0.8395 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7985 |
CYP450 2D6 Substrate | Non-substrate | 0.7830 |
CYP450 3A4 Substrate | Non-substrate | 0.6214 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.7502 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9260 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8092 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9280 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.7863 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9393 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Strong inhibitor | 0.5412 |
Inhibitor | 0.7675 |
AMES Toxicity | Non AMES toxic | 0.7534 |
Carcinogens | Non-carcinogens | 0.9346 |
Fish Toxicity | High FHMT | 0.8601 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9338 |
Honey Bee Toxicity | Low HBT | 0.6966 |
Biodegradation | Not ready biodegradable | 0.6718 |
Acute Oral Toxicity | III | 0.6717 |
Carcinogenicity (Three-class) | Non-required | 0.7667 |